Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma

Multiple Myeloma (MM), a clonal malignancy of antibody-producing plasma cells, is the second most common hematologic malignancy and results in significant patient morbidity and mortality. The high degree of immune dysregulation in MM, including T cell imbalances and up-regulation of immunosuppressiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyers, Daniel E., Thakur, Satbir, Thirukkumaran, Chandini M., Morris, Don G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802552/
https://www.ncbi.nlm.nih.gov/pubmed/29208938
http://dx.doi.org/10.1038/s41408-017-0020-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802552/
https://www.ncbi.nlm.nih.gov/pubmed/29208938
http://dx.doi.org/10.1038/s41408-017-0020-0

Ejemplares similares